News

News

The FDA is recalling a prescription blood thinner used to prevent stroke, heart attack, and other heart problems.

More than 70,000 bottles of calcium carbonate tablets are being recalled. 

A prescription antibiotic used to treat urinary tract infections caused by certain bacteria is being recalled.

“The magnitude of this benefit suggests that patients with pathogenic mutations in BRCA may benefit from intraperitoneal therapy,” researchers of a recent study explained. 

"Using the insulin pump did not necessarily give us good outcomes..." a researcher said. 

Earlier identification of older adults who will soon develop Alzheimer disease may be possible using a varied form of MRI.

The American College of Cardiology has released new guidance on the use of therapies for cardiovascular risk reduction in patients with type 2 diabetes and atherosclerotic cardiovascular disease.

About 276,000 more children are among the uninsured, a new report finds. Though the uptick is statistically small, it is striking because uninsured rates usually decrease during periods of economic growth.

The FDA has approved a biosimilar to Rituxan (rituximab; Genentech), for the treatment of adults with CD20-positive, B-cell non-Hodgkin’s lymphoma.

If a fifth of the 30 million patients with type 2 diabetes used dietary changes to drop their HbA1c level by 1%, the health care system could save at least $10 billion annually and outcomes would improve measurably, according to a recent report.